Recent advances in neuropharmacology for epilepsy management: Molecular targets, emerging antiepileptic drugs, pharmacokinetic and pharmacodynamic insights, and future directions in clinical pharmacotherapy

Read full text Summarise with VIRAT
Authors: Rahul Vijay Shetty, Shruti Dilip Kulkarni
Cited by: 0
References: 17

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Epilepsy is a persistent nervous system disorder that is associated with repeated and uncontrolled seizures caused by irregular and hyperirritable neuronal activity within the brain. It impacts almost 50 million individuals all over the planet and is among the most frequent neurological diseases with an extended pharmacological treatment. The progress in neuropharmacology has greatly enhanced the comprehension of molecular and cellular processes in epileptogenesis and propagation of seizure. They have made it possible to discover new targets of therapeutics including ion-channels, neurotransmitter-receptors, and synaptic-vesicle proteins which contribute to neuronal excitability as well as synaptive transmission. The years passed have brought a number of new antiepileptic drugs that have better safety profiles, better efficacy, and predictable pharmacokinetics. New anti-epileptic drugs like Levetiracetam, Brivaracetam, Perampanel and Lacosamide have enlarged treatment chances of epilepsy sufferers experiencing a state of refractory or drug-resistant epilepsy. Moreover, the pharmacodynamics and pharmacokinetic properties of the drugs have become critical in optimizing clinical practices and reducing drug adverse reactions. The current review is expected to summarize new developments in neuropharmacology in the context of epilepsy treatment, in terms of molecular targets, emerging antiepileptic drugs, and pharmacodynamics and pharmacokinetics to consider. Also, the future trends in clinical pharmacotherapy with the focus on precision medicine and new therapeutic options are addressed to outline the possible ways of how to advance epilepsy treatment and patient outcomes.

Fields of Study & Subjects

Epilepsy research and treatment Pharmacological Effects and Toxicity Studies Neuroscience and Neuropharmacology Research

Publication details

Journal / source
International Journal of Pharmacology and Clinical Research
Volume
8
Issue
3
Pages
158–164
Publication date
1 March 2026
Language
EN